The U.S. Supreme Court ruled unanimously that naturally occurring human genes cannot be patented, handing the plaintiffs in Association for Molecular Pathology v. Myriad Genetics a huge victory. The June 13 decision means that Myriad cannot control all testing or other work using two genes linked to a higher risk of breast and ovarian cancer. The ACLU was a pro bono attorney in the case, which also included as plaintiffs the American College of Medical Genetics, American Society for Clinical Pathology and other groups and individuals. The Supreme Court also ruled in favor of the American Trucking Associations in its lawsuit against the Port of Los Angeles. The decision… Read More